Botox 100 unit vials
Ended Awarded
- Contract number
- SPE2DB26FSV03
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,877
Award facts
- Contract value 100% obligated
- $13,877.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $13,877.10 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 100-unit vials of BOTOX. The award, issued on November 12, 2025, with an ultimate completion date of December 4, 2025, carries no set-aside designation, indicating DMS Pharmaceutical Group competed successfully in unrestricted federal procurement. Performance will occur at the contractor's Park Ridge facility.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (SPE2DR) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion government-wide acquisition strategy designed to establish regional pharmaceutical suppliers for Department of Defense healthcare operations. The underlying IDC, valued at $499.999 billion with a completion date of December 31, 2036, enables the agency to issue firm fixed-price delivery orders for branded and generic pharmaceuticals, biologics, and medical consumables to support military healthcare facilities globally. DMS Pharmaceutical Group's established performance across numerous recent delivery orders demonstrates its capability to fulfill specialized pharmaceutical requirements for the federal military medical system.
Quick answers
Who was awarded contract SPE2DB26FSV03?
SPE2DB26FSV03 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 12, 2025.
How much is contract SPE2DB26FSV03 worth?
The government has obligated $13,877 on SPE2DB26FSV03.
Is contract SPE2DB26FSV03 an order under another contract?
Yes. SPE2DB26FSV03 is a delivery order under SPE2DB22D9367, an indefinite delivery contract.
Was contract SPE2DB26FSV03 competed?
The extent of competition for SPE2DB26FSV03 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award